Brief: Hemcheck Sweden Q2 Oper Loss Widens To SEK 3.7 Mln
Aug 31 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* Q2 OPER LOSS SEK 3.7 MLN VS LOSS SEK 3.2 MLN YR AGO
Source text for Eikon: ID:nWkr9Pc1Xb
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln